To determine the influence of NASP expression levels on the radiotherapy response of patients with LGG and GBM, we compared the overall survival rates among patients with glioma in the CGGA database who received radiotherapy but not temozolomide chemotherapy. The gene discussed is NASP; the disease is central nervous system cancer.